|
N-Oxalylglycine
|
N-草酰<乙二酰>甘氨酸
|
5262-39-5
|
|
GSK J2
|
N-[2-(3-吡啶基)-6-(1,2,4,5-四氢-3H-3-苯并氮杂卓-3-基)-4-嘧啶基]-BETA-丙氨酸
|
1394854-52-4
|
|
IOX 1
|
5-羰基-8-羟基喹啉
|
5852-78-8
|
|
MCB-613
|
4-乙基-2,6-双(吡啶-3-基亚甲基)环己酮
|
1162656-22-5
|
|
Garcinol
|
山竹子素
|
78824-30-3
|
|
UNC 0642
|
2-(4,4-二氟-1-哌啶基)-6-甲氧基-N-[1-异丙基-4-哌啶基]-7-[3-(1-吡咯烷基)丙氧基]-4-喹唑啉胺
|
1481677-78-4
|
|
GSK J5
|
N-[2-(3-吡啶基)-6-(1,2,4,5-四氢-3H-3-苯并氮杂卓-3-基)-4-嘧啶基]-BETA-丙氨酸乙酯
|
1394854-51-3
|
|
OG-L002 HCl
|
OGL002; OG L002
|
1357298-75-9
|
|
AS8351
|
AS8351
|
796-42-9
|
|
TC-E 5003
|
N,N'-[磺酰基二(4,1-亚苯基)]二(2-氯乙酰胺)
|
17328-16-4
|
|
OICR-9429
|
OICR-9429
|
1801787-56-3
|
|
Entacapone
|
恩他卡朋
|
130929-57-6
|
|
GSK J4 free base
|
N-[2-(2-吡啶基)-6-(1,2,4,5-四氢-3H-3-苯并氮杂卓-3-基)-4-嘧啶基]-BETA-丙氨酸乙酯
|
1373423-53-0
|
|
MS023
|
N1-甲基-N1-[[4-[4-(异丙氧基)苯基]-1H-吡咯-3-基]甲基]-1,2-乙二胺
|
1831110-54-3
|
|
GSK J1
|
N-[2-(2-吡啶基)-6-(1,2,4,5-四氢-3H-3-苯并氮杂卓-3-基)-4-嘧啶基]-BETA-丙氨酸
|
1373422-53-7
|
|
1-Isoquinolin-6-Yl-3-[2-Oxo-2-(Pyrrolidin-1-Yl)ethyl]urea
|
N-6-异喹啉基-N'-[2-氧代-2-(1-吡咯烷基)乙基]脲
|
1687736-54-4
|
|
2,4-Pyridinedicarboxylic Acid
|
2,4-吡啶二羧酸
|
499-80-9
|
|
(R)-(+)-Etomoxir sodium salt
|
(R)-(+)-乙莫克舍钠盐
|
828934-41-4
|
|
PFI-2 (hydrochloride)
|
1627607-87-7
|
1627607-87-7
|
|
CPI-455
|
6-异丙基-7-氧代-5-苯基-4,7-二氢吡唑并[1,5-A]嘧啶-3-腈
|
1628208-23-0
|
|
RN-1 (hydrochloride)
|
RN1; RN 1
|
1781835-13-9
|
|
Butyrolactone 3
|
BUTYROLACETONE 3
|
778649-18-6
|